[Genetics and quaternary prevention. The example of haemochromatosis]
- PMID: 12975103
- PMCID: PMC7681808
- DOI: 10.1016/s0212-6567(03)79238-5
[Genetics and quaternary prevention. The example of haemochromatosis]
Similar articles
-
Haemochromatosis: a family study.Med J Aust. 1962 Nov 10;49(2):754-6. Med J Aust. 1962. PMID: 13952945 No abstract available.
-
[Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].Schweiz Med Wochenschr. 2000 Aug 8;130(31-32):1112-9. Schweiz Med Wochenschr. 2000. PMID: 11008304 German.
-
BLOOD GROUP DISTRIBUTION IN PATIENTS WITH HAEMOCHROMATOSIS.Vox Sang. 1965 Jan-Feb;10:107-8. doi: 10.1111/j.1423-0410.1965.tb04323.x. Vox Sang. 1965. PMID: 14294353 No abstract available.
-
The molecular genetics of haemochromatosis.Eur J Hum Genet. 2005 Nov;13(11):1172-85. doi: 10.1038/sj.ejhg.5201490. Eur J Hum Genet. 2005. PMID: 16132052 Review.
-
[Diagnosis and treatment of genetic haemochromatosis].Ugeskr Laeger. 2013 Apr 15;175(16):1109-12. Ugeskr Laeger. 2013. PMID: 23651749 Review. Danish.
References
-
- Reventlow S., Hvas A.C., Tulinius C. In really great danger. The concept of risk in general practice. Scand J Prim Health Care. 2001;19:71–75. - PubMed
-
- Holtzman M.A., Marteau T.M. Will genetics revolutionize medicineα. N Engl J Med. 2000;343:141–144. - PubMed
-
- Pérez Fernández M., Gérvas J. Encarnizamiento diagnóstico y terapéutico con las mujeres. Semergen. 1999;25:239–248.
-
- Pérez Fernández M., Gérvas J. El efecto cascada: implicaciones clínicas, epidemiológicas y éticas. Med Clin (Barc) 2002;118:165–167. - PubMed
-
- Gérvas J., Pérez Fernández M. Las hiperlipemias y la prevención primaria de la cardiopatía isquémica. Med Clin (Barc) 1997;109:549–552. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical